Exam 1 Flashcards

1
Q

cardiac hypertrophy or cardiomegaly

A

any increases in size or particularly in increases in masses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Left ventricular hypertrophy

A

A nything that should exceed that, so say more than 15mm, (normal is 13-15)

a cellular, structural response to a variety of insults.

consequences of both pumping against increased pressure and you also reduce the cardiac output because of reduced stroke volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

right ventricular hypertrophy

A

anything above that 5mm threshold (normal is 3-5mm)

cor pulmonale: primary pulmonary hypertension will lead to right sided changes in the heart.

 Pulmonary arteries hypertrophy, constrict, and sclerose
 Persistent elevations in pressure result in right to left shunt (Eisenmenger syndrome)
 After birth, blood flow from right to left results in hypoxemia and cyanosis
 Bypasses the pulmonary circulation
 Emboli from veins to the systemic circulation (paradoxical emboli)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cardiac dilation or dilatation

A

increase chamber size often related to disease state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Microscopic consequence of systemic hypertension

A

increased production of sarcolemma proteins and markedly enlarged, what we call boxed car nuclei, with thickened myofibrils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Three major coronary arteries

A

Left anterior descending (breaks into diagonal branches)

Left circumflex (Marginal branches)

Right Coronary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pathologic changes of the valves

A

Damage to collagen that weakens the leaflets

Nodular calcification

Fibrotic thickening

Secondary changes:

Ventricular dilation

Tendinous cord rupture

Papillary muscle dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Left to right shunts

A

result in an increase in pulmonary blood flow

Elevate both volume and pressure in the low-pressure, low- resistance pulmonary circulation

Most common congenital heart disease

Symptoms vary from asymptomatic to fulminant heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ventricular septal defects

A

o incomplete closures of the ventricular septum, allowing free communication of blood between the left and right ventricles
o most common form of congenital heart disease
o 90% occur in the region of the membranous interventricular septum (membranous VSD)
o 10% occur below the pulmonary valve (infundibular VSD)
o Functional consequences of a VSD depend on the size of the defect and associated right-sided malformations
o Lead to early right ventricular hypertrophy and pulmonary hypertension
o Irreversible pulmonary vascular disease, shunt reversal, and death
o 50% CLOSE SPONTAEOUSLY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Atrial septal defects

A

o Abnormal, fixed openings in the atrial septum caused by incomplete tissue formation
o Usually asymptomatic until adulthood
o left to right shunts, increased pulmonary blood flow, and murmurs
o Pulmonary hypertension is unusual
o Secundum ASD (90%) results from a deficient septum secundum formation
o Primum anomalies or sinus venosus defects (10%) occur adjacent to the AV valves or the entrance of the SVC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Patent Ductus Arteriosus

A

o The ductus arteriosus arises from the pulmonary artery and joins the aorta just distal to the origin of the left subclavian artery
o PDAs cause a characteristic continuous harsh “machinery-like” murmur
o Large defects can lead to volume and pressure overloads in the small pulmonary arteries, reversal, and associated consequences
o May be life saving for infants with other congenital abnormalities that obstruct pulmonary or systemic outflow tracts (TOF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Tetralogy of Fallot

A

o RIGHT TO LEFT SHUNT*
o Four features
 VSD
 Obstruction of the right ventricular outflow tract (pulmonary stenosis)
 Overriding aorta
 Right ventricular hypertrophy
o Boot shaped heart
o Severity = based on the ability of the right heart to pump blood and adequate amount of blood into the pulmonary circulation
 pink tetralogy: you may only have a left-to-right shunt because you haven’t built up pressures sufficiently to cause the right to left; mild and may not require surgery
 most infants are symptomatic at birth and will require immediate surgery right after birth.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Transition Of The Great Arteries

A

o produces ventriculoarterial discordance
o Aorta arises from the right ventricle/ Pulmonary artery arises from the left ventricle
o Atrium-to-ventricle connections are normal
o Early survival depends on accompanying shunting defects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Obstructive Lesions

A

o Congenital obstruction can occur at the level of the heart valves, within a great vessel, or within a chamber
 Aortic or pulmonary valve stenosis or atresia
 Outflow obstruction in TOF
 Coarctation of the aorta
• constricting or narrowing of the aortic arch
• Infantile
o Often symptomatic in early childhood with tubular hypoplasia of the aorta arch proximal to the ductus
• Adult
o Discrete, ridge-like infolding of the aorta just opposite of the closed ductus
• with PDA usually manifests early in life due to the delivery of unsaturated blood through the lower part of body
• without PDA often goes unrecognized until adulthood
o Hypertension of the upper extremities
o Hypotension of the lower extremities
o Development of collateral circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Six principal mechanisms of Cardiac Dysfunction

A
  1. Pump failure
  2. Flow obstruction
  3. Regurgitant flow
  4. Shunted flow
  5. Disorders of cardiac conduction
  6. Rupture of the heart or a major vessel
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Congestive heart failure

A

occurs when the heart is unable to pump blood at a rate sufficient to meet the metabolic demands of the body tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Malignant hypertension

A

o a rapidly rising blood pressure that if left untreated will die within 1 -2 years
o Systolic BP above 200 mm Hg/Diastolic BP above 120 mm Hg
o Renal failure/ Retinal hemorrhages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Arteriosclerosis

A

hardening of the arteries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Hyaline Arteriolosclerosis

A

 Pink hyaline thickening with associated luminal narrowing

 Plasma protein leakage across injured endothelial cells leading to increased smooth muscle matrix synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Hyperplastic Arteriolosclerosis

A

 Concentric, laminated, onion- skinning thickening of the walls with luminal narrowing
 Consists of smooth muscle cells with thickened, reduplicated basement membranes
 May lead to necrotizing arteriolitis in malignant hypertension, particularly in the kidneys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Atherosclerosis

A

o form of arteriosclerosis caused by the build up of fatty plaques within the arterial walls
o underlying pathology of coronary artery, cerebral, and peripheral vascular disease (the main driver for end organ damage within the cardiovascular system)

a chronic inflammatory and healing response of the arterial wall to endothelial injury

Lesion progression occurs due to complex interactions of lipoproteins, macrophages, T- cells, and smooth muscle cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Modifiable Risk Factors for Atherosclerosis

A
Diabetes mellitus
Unhealthy diet
Inactivity
Obesity
Alcohol use
Smoking
Hyperlipidemia
Low-density lipoproteins 
Systemic inflammation
Hyperhomocystinemia
Metabolic syndrome
Insulin resistance, hypertension, dyslipidemia,  hypercoagulability, and a proinflammatory state
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Pathophysiology of Atherosclerosis

A

Endothelial injury or dysfunction

Accumulation of lipoproteins

Monocyte adhesion to the endothelium

Platelet adhesion

Factor release

Smooth muscle cell proliferation

Lipid accumulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What percent decrease in luminal diameter is needed to reach critical stenosis in the coronary arteries?

A

70% decrease in the luminal diameter for critical stenosis and subsequent tissue ischemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Angina pectoris

A

“chest pain” in response to reaching the point of critical stenosis and the vessels are not able to respond in times of increased demand

FANCY ANSWER: paroxysmal and usually recurrent attacks of substernal or precordial chest discomfort caused by transient myocardial ischemia that is insufficient to induce myocyte necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Stable angina

A

“Chest pain with exertion”

A stable plaque that’s 70-80% occluded, so, when your heart requires, because of the activity, more oxygen delivered – increased contractility – your vessel cannot respond to that by delivering increased amount of blood and oxygen causing pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Unstable angina

A

“Chest pain at rest”

You’re probably well above the 70% mark, approaching 80-90%. Even at base line contractility of the heart, the coronary arteries are not able to deliver as much oxygen as necessary.

plaque disruption can then result in thrombosis and vasoconstriction without total occlusion, so you can develop a thrombus in that area as a response to plaque disruption.

A person can go from unstable to stable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Plaque Disruption

A

Plaques erode or rupture when they are unable to withstand mechanical stresses generated by vascular shear forces

Plaque rupture results in the release of the necrotic lipid core, and rapid recruitment of platelets

Plaque rupture is typically promptly followed by partial or complete vascular thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Myocardial Infarction

A

heart attack

Death of cardiac muscle due to prolonged and severe ischemia

The incidence of MI strongly correlates with genetic and behavioral predispositions to atherosclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

most common cause of death in older women

A

Ischemic heart disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Epi of MI

A

45% occur in people younger than 65
10% of MIs occur in people younger than 40

Blacks and white are equally affected

In middle age, men have a higher relative risk
Women are generally protected during reproductive years

Postmenopausal decline in estrogen production is usually associated with accelerated coronary artery disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Process of a Heart Attack

A

Coronary artery atheromatous plaque undergoes an acute change

When exposed to subendothelial collagen and necrotic plaque contents, platelets adhere, become activated, and aggregate

they are going to vasospasm and constrict further in response to these local mediators (so instead of dilating, they constrict).

Tissue factor activates the coagulation cascade, adding the bulk of the thrombus

Occlusion can occur within minutes

Obstruction diminishes the blood flow to the region of the myocardium.

Within seconds the oxygen will be depleted and without oxygen, aerobic metabolism will stop

Noxious metabolites (lactate) accumulate

Myocardial contractility ceases

Ultrastructural changes occur in the myocyte
Myofibrillar relaxation, glycogen depletion, mitochondrial swelling
(Reversible!!)

In about 20 – 30 minutes, myocyte necrosis begins
2 – 3 hours of half thickness
6 hours for transmural
(Irreversible!!)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

MI Timeline

A
Within 30 minutes
Relaxation of myofibrils
Glycogen loss
Mitochondrial  swelling
(Reversible injury)

30 minutes – 4 hours
Sarcolemmal disruption and mitochondrial densities
No gross findings
Subtle waviness of mycoytes at the border of the infarct

4 – 12 hours
Beginning to have dark mottling
Early coagulation necrosis, edema, and hemorrhage

12 – 24 hours
Dark mottling
Ongoing coagulative necrosis
Pyknosis of nuclei
Hypereosinophilia of myocytes
Contraction band necrosis
Early neutrophilic infiltrate

1 – 3 days
Mottling with yellow-tan infarct center
Coagulation necrosis with loss of nuclei and striations
Brisk neutrophilic infiltrate

3 – 7 days
Hyperemic border with central yellow-tan  softening
Disintegration of dead myofibers
Dying neutrophils
Macrophages at infarct border
7 – 10 days 
peak of macrophages 
maximally yellow-tan  & soft depressed tissue at the site of the infarct
 brisk phagocytosis
Granulation tissue at the margins

10 – 14 days
Red-gray depressed borders
Well established granulation tissue with new blood vessels and early collagen deposition

2 – 8 weeks
Grey-white scar from border to center
Collagen deposition
Decreased cellularity

> 2 months
Complete scar
Dense collagen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

When is the time period where you are most vulnerable to complication down the road, if you survive the heart attack and the heart is at its most weakened?

A

3 – 7 days

macrophages are chomping up on the dead myocytes and the nuclear debris.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Summarized Timeline

A

So the earliest change that we find is sort of this wavy, maybe hyper-eosinophilic area - these are the earlier microscopic changes that we see.

Next step in the process is the recruitment of neutrophils – this occurs in the 12-24 hour mark

As we progress, neutrophils will be replaced by macrophages

Macrophages[replaced] by smooth muscle cells & fibroblast depositing collagen

Ultimately you’re left with fibrosis in that area if you survive & the development of a collagenous scar (bottom right)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

LAD supplies…

A

most of the apex, the anterior wall of the LV, and the anterior 2/3 of the ventricular septum
– The dominant artery perfuses the posterior 1/3

occlusions account for 40 – 50% of myocardial infarcts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

RCa supplies…

A

the entire right ventricular free wall and the posterobasal wall of the LV

occlusions account for 30 – 40% of myocardial infarcts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

LCx supplies…

A

the lateral wall of the LV

occlusions account for 15 – 20% of myocardial infarcts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Transmural infarction

A

Caused by occlusion of a vessel with full thickness necrosis of the myocardium
Usually caused by chronic coronary atherosclerosis, acute plaque changes, and thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Subendocardial infarction

A

Partial thickness, although that can occur in complete occlusions

The subendocardial zone is normally the least perfused region and is most vulnerable to disruptions in flow

May result from severe, prolonged reduction in systemic blood pressure in individuals with otherwise non-critical stenosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Multifocal infarction

A

Typically seen with pathology involving the small intramural vessels

Microembolization, vasculitis, vasospasms like someone who uses cocaine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

MI Presentation

A

Typically present with prolonged chest pain described as crushing, stabbing, or squeezing

Often associated with a rapid weak pulse, diaphoresis, and nausea and vomiting

25% may be entirely asymptomatic
– Diabetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

MI Diagnosis

A

diagnosed by clinical symptoms, laboratory tests, and characteristic EKG changes

Laboratory diagnosis exploits blood levels of proteins that leak out of irreversibly damaged myocytes
– Troponins, CK-MB, lactate

Troponins rise later than all the other proteins but STAY HIGH LONGER after an MI***

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

MI Treatment

A
Morphine to relieve pain
Reperfusion
Antiplatelet agents
Anticoagulation
Nitrates for induce vasodilation
Beta blockers to decrease myocardial oxygen demand
Antiarrhythmics to manage arrythmias
Angiotensin converting enzyme to limit ventricular dilation
Oxygen supplementation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Myocardial Rupture

A

3 – 5 days after an MI are most at risk

you can end up with rupture of the left ventricular free wall which leads to hemopericardium or blood within the pericardial sac.. That blood will compress the heart, reduce its ability to contract & that leads to condition called cardiac tamponade.

You can also develop ruptures of the ventricular septum if that’s the area that was infarcted.. This can develop a function ventricular septal defect & a left to right shunt & all of the complications that occur because of that.

The papillary muscles in subendocardial ischemia or transmural.. can rupture which can lead to an onset of severe mitral regurgitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Chronic Ischemic Heart Disease

A

progressive congestive heart failure as the result of accumulated ischemic myocardial damage

usually appears after an infarction due to the functional decompensation of the hypertrophied, noninfarcted myocardium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Ischemic heart disease leads to the development of…

A

Left ventricular hypertrophy
Cardiac dilation
Cardiomegaly
Heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Valvular Disease

A

most commonly stenosis, insufficiency, or some combination of both.

Valvular stenosis is a failure of the valve to open completely, which is going to impede FORWARD flow

Valvular Insufficiency results from a failure of a valve to CLOSE completely, so this leads to regurgitation or REVERSED flow, so pressure overload in the chamber prior to

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Primary vs. Secondary Valvular Disease

A

Primary: defects & generation of the valvular tissue ITSELF

Secondary or functional insufficiency: often happens because of DILATION of one of the CHAMBERS of the heart, so dilation of the left ventricle may prevent the proper closure of an otherwise normal valve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Most common acquired valvular diseases

A
  1. Aortic stenosis
  2. Aortic insufficiency
  3. Mitral stenosis
  4. Mitral insufficiency

So left sided heart problems are the ones that are the most common, most frequently encountered.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Aortic stenosis

A

Calcification and sclerosis of anatomically normal or congenitally bicuspid aortic valves

Consequence of recurrent chronic injury due to factors similar to atherosclerosis in other areas
Hyperlipidemia
Hypertension
Inflammation
Chronic progressive injury leads to valvular degeneration and incites deposits of hydroxyapatite (same calcium found in bone)

Obstruction to the left ventricular outflow tract leads to gradual narrowing of the valve orifice and an increasing pressure gradient across the valve
Left ventricular pressures rise
Left ventricular hypertrophy
Systolic and diastolic dysfunction occur
Angina, congestive heart failure, and death

TXT: Valve replacement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Aortic insufficiency

A

Dilation of the ascending aorta secondary to hypertension or aging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Mitral stenosis

A

Rheumatic heart disease

Rheumatic fever is an acute, immunologically mediated, multisystem inflammatory disease classically occurring a few weeks following group A streptococcal pharyngitis

Results from a host immune response to GAS antigens that cross react with host proteins
Antibodies against streptococcal M proteins that cross react with cardiac self antigens
Leads to complement activation, cytokine production, and T-cell/macrophage activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Mitral insufficiency

A

Myxomatous degeneration

Marked thickening of the spongiosa layer with deposition of myxomatous material
Attenuation of the collagenous fibrosa layer

Secondary changes
Fibrous thickening of the leaflets
Fibrous thickening of the left ventricular endocardial surface
Thrombi on the atrial surface of the leaflets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Mitral Annular Calcification

A

degenerative changes in the mitral valves typically affect the fibrous annulus

Leads to irregular, stony hard, sometimes ulcerated nodules at the base of the leaflets

Usually doesn’t affect valvular function
Regurgitation to due contraction of the valve ring
Stenosis by impairing valve opening
Arrhythmias due to penetration of calcium into the atrioventricular conduction system

These calcific nodules provide a site for thrombus formation
Increase risk of embolic stroke and infective endocarditis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Mitral Valve Prolapse

A

one or both of the mitral valve leaflets are floppy and balloon back into the left atrium during systole

Affects 2 – 3 % of individuals in the US

7:1 female to male ratio

Often benign, but may lead to sudden cardiac death

Leaflets are enlarged, redundant, thick, and rubbery

The tendinous cords may be elongated, thinned, or ruptured

Mitral valve annulus is dilated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

What is found during Rheumatic Fever?

A

focal inflammatory lesions are found in various tissues

Aschoff bodies in the heart

Foci of T lymphocytes, occasional plasma cells, and activated macrophages

Anitschkow cells
Pathognomonic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Acute Rheumatic Fever

A

Diffuse inflammation and Aschoff bodies may be found anywhere in the heart

Inflammation of the endocardium and left-sided valves result in fibrinoid necrosis within the cusps or tendinous cords

Overlying these necrotic foci are small vegetations (verrucae)

Subendocardial lesions develop (MacCallum plaques

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Valve most commonly seen effected by Rheumatic fever?

A

Mitral Valve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Pathologic changes in RF

A

a fish mouth deformity of the valve (fusion of the commissures here so the normal mitral leaflets start to thicken, they get fused here at the commissures)
Tight mitral stenosis
Progressive left atrium dilation
Pulmonary congestion and vascular changes
Right ventricular hypertrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

Comparison between mitral prolapse and mitral stenosis from RF?

A

In contrast to mitral valve prolapse, where had thinning and elongation of the tendinous cords, we see thickening and reduplication of these cords which can cause further dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Rheumatic Fever Clinical

A

Characterized by
Migratory polyarthritis of the large joints
Pancarditis  inflammation of the heart muscle
Subcutaneous nodules
Erythema marginatum of the skin
Sydenham chorea
Involuntary, rapid, purposeless movements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Infective Endocarditis

A

microbial infection of the heart valves or mural endocardium (just adjacent to the valves) that leads to the formation of (infected) vegetations

Often associated with destruction of the underlying cardiac tissues (as well as the valves themselves)

Most infections are bacterial (but there are a wide variety of causes)

Classified into acute and subacute forms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

Acute endocarditis

A

typically caused by infection of a previously normal heart valve by a highly virulent organism (Staph aureus)
Rapidly produces necrotizing and destructive lesions
Difficult to cure with antibiotics alone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

Subacute endocarditis

A

endocarditis is typically cause by organisms with lower virulence (Strep viridans) that cause insidious infections of deformed valves

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

most important predisposing factors to developing endocarditis

A

Obvious infection
Contaminated needle shared by IVDU
Dental or surgical procedures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

Nonbacterial thrombotic endocarditis

A

Sterile vegetations characterized by deposition of small sterile thrombi on the leaflets of the cardiac valves

Single or multiple

Nondestructive

Illicit no inflammatory response

May embolize

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

Libman-Sacks endocarditis

A

Mitral or tricuspid valvulitis with small sterile vegetations
Occasionally encountered in systemic lupus erythematosus
Single or multiple
Located on the undersurfaces of the atrioventricular valves
Associated with intense valvulitis

INFLAMMATION!!!*

these are the only lesions that are located on the undersurface of valves**

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

Three major morphologic patterns of cardiomyopathy

A

Dilated cardiomyopathy
Hypertrophic cardiomyopathy
Restrictive cardiomyopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

Dilated Cardiomyopathy (DCM)

A

most common (90% of cases)

Characterized by progressive dilation and systolic dysfunction, usually with concomitant hypertrophy
– Ejection fraction < 40%

Genetic factors, alcohol, peripartum, myocarditis, hemochromatosis, chronic anemia, doxorubicin toxicity, sarcoidosis

Enlarged, heavy, and flabby heart
– Dilation of all four cardiac chambers

Mural thrombi are common

May result in secondary valvular dysfunction

Typically affects those between 20 and 50

Presents with slowly progressive signs and symptoms of CHF
– Dyspnea, fatigue, poor exertional capacity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

Hypertrophic Cardiomyopathy

A

common, clinically heterogenous, genetic disorder characterized by myocardial hypertrophy, poorly compliant left ventricular myocardium leading to abnormal diastolic filling, and intermittent ventricular outflow obstruction

Thick walled, heavy, and hypercontracting
Ejection fraction is 50 – 80%

Autosomal dominant disorder with variable penetrance

Banana-like left ventricular cavity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

Central abnormality in HCM

A

reduced stroke volume due to impaired diastolic filling
Reduced chamber size
Reduced compliance of the ventricle

Those with significant outflow obstruction develop increased pulmonary venous pressures and dyspnea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

hypertrophic obstructive cardiomyopathy

A

this is the characteristic young athlete, who had no problems but just died suddenly during the filed of play

Intramural arteries thicken
Focal myocardial ischemia is common
Atrial fibrillation
Ventricular arrhythmias
Mural thrombi and embolization
Cardiac failure
Sudden death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

Restrictive Cardiomyopathy

A

characterized by a primary decrease in ventricular compliance resulting in impaired ventricular filling during diastole
– Ejection fracture 45 – 90%

Systolic function is usually unaffected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

Causes of Restrictive Cardiomyopathy

A
Radiation
Amyloidosis
Sarcoidosis
Metastatic tumors
Inborn errors of metabolism

(secondary changes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

Myocarditis

A

a diverse group of pathologic entities in which infectious microorganisms and/ or a primary inflammatory process cause myocardial injury

May cause direct myocyte injury or elicit a destructive immune response

The intense cytokine response produces myocardial dysfunction out of proportion to the degree of actual myocyte damage

Myocarditis is a PRIMARY disease, and should be distinguished from secondary causes of inflammation (ie, ischemic heart disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

Causes of Myocarditis

A

Viral infections are the most common cause of myocarditis in the US
Coxsackie A and B and other enteroviruses
Occasionally, CMV, HIV, and influenza may be implicated

Nonviral agents are common outside of the US
Trypanosoma cruzi, trichinella spiralis, toxoplasmosis, borrelia burgdorferi, and Corynebacterium diphtheriae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

Pericarditis

A

inflammation can occur secondary to a variety of cardiac, thoracic, or systemic disorders, metastases, or cardiac surgical procedures

Primary pericarditis is rare (viral)

Serous pericarditis
Characteristically produced by non-infectious diseases (RF, SLE, scleroderma, tumors, and uremia)
Fibrinous pericarditis
Most frequent type of pericarditis
Serous fluid mixed with fibrinous exudate
Acute MI, postinfarction syndrome (Dressler syndrome), uremia, radiation, RF, SLE, and trauma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

Primary cardiac tumors

A
Myxomas (most common tumor in adults)
Fibromas
Lipomas
Papillary fibroelastomas
Rhabdomyomas (most common pediatric tumor)
Angiosarcomas

**Most common heart tumor is a metastasis**

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

respiratory epithelium

A

pseudostratified columnar with cilia and goblet cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

2 types of pneumocytes

A

Type 1- where gas exchange occurs and really hard to see.
Long thin cell with a very small nucleus. Gas exchange occurring across the cytoplasm.
As you breathe in the oxygen. they are at high risk of dying so they have a high turnover rate.

Type 2-can terminally differentiate and become type 1 cells. They also have macrophage functions. They also make surfactant.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

Surfactant and newborns

A

what surfactant does is it follows La Place’s Law and it lines these airways. And it decreases surface tension. So by having a hydrophobic surface towards the center of the alveoli, the fluid is thinned out and surface tension is less. And that’s important because the second breath the child takes is against less resistance because the child is not born with great muscles, they’re thin as can be.

. So they realized that if you gave surfactant to a child born before 24 weeks, they could survive.

Also give steroids to the mother to jack up surfactant production by the type 2 pneumocytes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

Pulmonary function tests

A

TLC: total lung capacity (5 to 7 l)
VC: vital capacity (3 to 5 l) TV: tidal volume (1 to 2 l)
FVC: forced vital capacity (3 to 4 l)
FEV1: forced expiratory volume in 1 second (2 to 3 l) FEV1/FVC ratio (60 to 70%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

Three mechanisms to have obstructive lung disease

A

You can have obstruction because there’s something blocking the way (fluid or mucus)

You can have decreased diameter because the muscular hypertrophy or construction

You can have a loss of tether

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

Three types of obstructive lung disease with their definitions

A

Emphysema: abnormal permanent enlargement of airspaces without obvious fibrosis

Chronic bronchitis: persistent cough with sputum for at least 3 months in at least 2 consecutive years

Asthma: hyperreactive airways leading to episodic reversible bronchoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

Emphysema

A

so you can breathe the air in. But you can’t get that carbon dioxide out which is bad for two reasons.

One, the carbon dioxide levels are going to rise in your blood. But number two you don’t have room for more oxygen.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

Emphysema Supersimplified pathogenesis

A

tip the balancing act towards the elastases and the enzymes will destroy the lung and break down the lung. (Neutrophil elastase Proteinase 3 Cathepsins
Matrix metalloproteinases) and away from the “anti-enzymes” (1-Antitrypsin
Secretory leukoprotease inhibitor Elafin
Tissue inhibitors of matrix metalloproteinases)

Example is Tobacco blocks the antitrypsin and leads to the influx of a lot of neutrophils; and neutrophils stimulate the release of these proteins as well. So anything that leads to break down the lung and prevents the breakdown of lung, will lead to dissolving are melting of the lung tissue and that’s what causes emphysema.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q

Emphysema a1-antitrypsin deficiency

A

1-2% of patients with COPD

Autosomal recessive disorder

1AT is a serine protease inhibitor—elastase Made in the liver

Defective 1AT does not neutralize elastase—emphysema Defective 1AT accumulates in the liver—cirrhosis

Mutated SERPINA1 gene

PiZZ—panacinar emphysema at a young age
PiSS, PiMZ and PiSZ–reduced levels of normal—emphysema if smokers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q

Chronic bronchitis

A

You plug the airways with mucus . So a smoker is most risk of developing this because the tobacco smoke harms the respiratory epithelium and predisposes to infection. So then you keep getting infections of the airways you get bronchitis, you get pneumonia, you get bronchitis

Bronchiolar and bronchial injury leading the bronchospasm, and hypersecretion of mucus, infection.
Obstruction and airways continued in repeated injury, smoking, continued in repeated infection chronic bronchitis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
90
Q

Asthma

A

You got more goblet cells than normal. You’ve got inflammatory cells. You’ve got thickened muscle and way too many seromucinous glands. So all of that is a response to whatever this immune trigger is. Bronchoconstriction leads to muscle thickening. Whatever the insult is damages the epithelium and leads to more seromucinous gland production of fluids and also hypertrophy of the seromucinous glands.

Asthma Focus on T-cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
91
Q

Process of Asthma

A

an antigen being presented by a macrophage and then shit really hits the fan because the T cells get revved up and they stimulate the B cells which secretes the antibodies that cross link on the mast cell. That lead to lead mediator release of leukotrienes, cytokines, and histamines and cause bronchospasm and edema and airway inflammation and so on.

Still don’t have a way to stop the T cells, so we treat asthma the same old fashioned way with bronchodilators and steroids. Bronchodilators to help the airways stay open and steroids to try and knock down this inflammatory cascade.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
92
Q

Atelectasis

A

Incomplete expansion or collapse of lung (airless lung)

REVERSIBLE DISORDER

3 types

Resorption atelectasis: due to airway obstruction

Compression atelectasis: due to pleural cavity expansion hemothorax, pneumothorax

Contraction atelectasis: due to lung or pleural fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
93
Q

Restrictive lung diseases

A
Spinal disorders
Neurologic disorders  
Sarcoidosis
Hypersensitivity pneumonitis 
Pneumoconiosis
Idiopathic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
94
Q

Hypersensitivity pneumonitis

A

Extrinsic allergic alveolitis
Immunologic reaction to inhaled antigens Antigens not identified in up to 66% of cases Acute and chronic presentations

ACUTE PRESENTATION

Single large bolus exposure to antigen
Dyspnea, cough, fever/chills 4-6 hours later

 CXR: diffuse granular infiltrates
Pathology: Pulmonary edema
Pathogenesis: Type III hypersensitivity reaction (immune complex disease)  
Prognosis: Improvement in a day or so
Reexposure: Recrudescence

CHRONIC PRESENTATION

Prolonged exposure to small amounts of antigen Insidious dyspnea, dry cough, fatigue

CXR: Mostly upper lobe interstitial reticulonodular infiltrates Lab: serum antibodies, skin tests?
BAL: Increased CD8+ lymphocytes
Pathology: Chronic bronchiolitis, interstitial pneumonia, and granulomas Pathogenesis: Type III and IV hypersensitivity reactions
Prognosis: Improvement in 33%, stable in 33%, worsening in 33% if antigen not removed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
95
Q

Hypersensitivity Pneumoconiosis

A

Pathologic response related to:
intensity of exposure
duration of exposure quantity of exposure size of particle
physiochemical properties of particle route of clearance
efficiency of clearance host response
interactions with other environmental pollutants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
96
Q

examples causing pneumoconiosis

A
Asbesto
Silica
Silicates (talc, kaolin, mica)  
Mixed dust
Coal  
Metals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
97
Q

fluid filled skin lesions

A

Vesicle: a circumscribed collection of free fluid less than 0.5cm in diameter

Bulla: a circumscribed collection of free fluid greater than 0.5cm in diameter

Pustule: a circumscribed collection of purulent exudate that varies in size (pimples)

Cyst: a cavity containing fluid or semisolid material surroudned by an epithelial layer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
98
Q

Disorders of Pigmentation and Melanocytes

A

Freckle
Lentigo
Melanocytic Nevi
Melanoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
99
Q

Freckles

A

small- Focal abnormality in pigment production

Hyperpigmentation: increased amount of melanin pigment. Normal density of melanocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
100
Q

Lentigo

A

Liver spots- age spots

They’re not related to sunlight exposure, they are stable in color that’s why they are very difficult to remove.

The pathology is unknown

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
101
Q

Excessive melanotic maculae in the oral and perioral distribution related to which two diseases?

A

Addison’s disease

Peutz-Jeghers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
102
Q

Addison’s Disease

A

Adrenal failure
Activation of pituitary gland leading to increased ACTH and MSH .
Stimulate melanocytes in the skin and mucosa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
103
Q

Peutz-Jeghers

A

INHERITED!!! (they’re going to have a family history)

They’ll also have other things in the skin and GI tract too.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
104
Q

Neurofibromatosis

A

Café au lait spots

Histologically similar- larger and arise independently of sun exposure

Neurofibromatosis is more a genetic disease and this is only one of the manifestations of that because the location of the skin lesions, different types of tumors, and even manifestations on the eyes too.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
105
Q

Vitiligo

A

Hypopigmentation (loss of melanocytes or melanin production)

Melanocytes are destroyed
White patches of skin
May be an autoimmune disease

May be associated with another autoimmune disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
106
Q

Melanocytic Nevus (Pigmented Nevus Mole)

A

Benign neoplasms

Numerous subtypes

Acquired are the most common type

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
107
Q

Dysplastic Nevi

A
May be direct precursors of melanoma
Many never progress
Mutations or epigenetic changes
NRAS and BRAF genes
Inherited loss of function mutations in  CDKN2A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
108
Q

Melanoma

A

Most deadly of all skin cancers
Strongly linked to acquired mutations caused by exposure to UV radiation in sunlight

Relatively common neoplasm
Some studies suggest that periodic sunburns early in life are the most risk factors
Predisposing factors/environmental factors
Mutations in cell cycle regulators

Blistering sunburn can double the chances of developing melanoma later in life

Strong dose-response relationship

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
109
Q

ABCs of Melanoma

A
Asymmetrical
Borders (irregular)
Color 
Diameter (1/4in or 6mm) 
Evolving (changing)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
110
Q

Melanoma Therapy

A

Antibody Therapy

Chemotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
111
Q

Compared to those who have never tanned indoors, indoor tanners….

A

have a 20% percent higher risk of melanoma

have an 87% higher risk of melanoma if they start tanning before 35

are 2.5 times more likely to develop SCC and 1.5 more likely to develop Basal cell carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
112
Q

Benign Epithelial Tumors

A

Seborrheic Keratoses

Acanthosis Nigricans

Fibroepithelial Polyp

Epithelial or Follicular

Inclusion Cyst

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
113
Q

Tumors of the Dermis

A

Benign Fibrous Histiocytoma

Dermatofibrosarcoma Protuberans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
114
Q

Tumors of Cellular Migrants of the Skin

A

Mycosis Fungoides

Mastocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
115
Q

Acanthosis Nigricans

A

Dark velvety patches
May be an important sign of underlying conditions
GI Adenocarcinomas- middle aged and older individuals
Type 2 diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
116
Q

Fibroepithelial Polyp or intraoral Polyp

A

skin tag

intraorally associated with an area of trauma usually

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
117
Q

Premalignant and Malignant Epidermal Tumors Related to Sun Exposure

A

Actinic Keratosis
Squamous Cell Carcinoma
Basal Cell Carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
118
Q

Actinic Keratosis

A

Sun damaged skin-hyperkeratosis

Exposure to ionizing radiation and arsenicals

It seems like the skin is very dry, but they’re going to have this type of ulcerations.. But these ulcerations are not healing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
119
Q

Squamous Cell Carcinoma

A

DNA damage induced by exposure to UV light

P53 dysfunction

Can progress from actinic keratosis, chemical exposure, thermal burn sites or in association with HPV infection in the sitting of immunosuppression

Cutaneous cell carcinoma has potential for metastasis but is less aggressive than squamous cell carcinoma at mucosal sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
120
Q

Basal Cell Carcinoma

A

Locally aggressive tumor

Rarely metastasize

Pearly papules containing prominent blood vessels ( telangiectasias)

Advanced lesions may ulcerate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
121
Q

Acute Inflammatory Dermatoses

A

Urticaria
Acute Eczematous Dermatitis
Erythema Multifomre

acute lesions-days to weeks
Inflammatory infiltrates-edema

122
Q

Urticaria

A

hives – mast cell degranulation
Antigen induced release of vasoactive
mediators from the mast cells

123
Q

Eczematous dermatitis

A

T cell-mediated inflammatory reactions
(type IV hypersensitivity)

Acute allergic reaction due to antigen exposure

124
Q

Erythema Multiforme

A

Uncommon – self-limited hypersensitivity reaction to certain infections and drugs

Macules, papules, vesicles, bullae Any age
Herpes simplex, penicillin, barbiturates, salicylates, cancer (lymphomas), lupus, polyarteritis nodosa.

CHARACTERISTICS
Target like lesions Central necrosis Macular erythema

125
Q

Stevens-Johnson syndrome

A

A febrile form associated with extensive involvement of the skin
Fever-flu like symptoms
Often in children but not exclusively

Blisters

Complications: Dehydration, sepsis
pneumonia
Multiple organ failure

Etiology

Medications- Antibiotics, carbamazepine and others
SLE HIV/AIDS
Immune reaction

126
Q

Toxic Epidermal Necrolysis (TEN)

A

Defuse necrosis- cutaneous and mucosal epithelial surfaces
Flu like symptoms
A history of drug exposure Large blisters

More severe than SJS

Dehydration, sepsis, pneumonia and multiple organ failure

127
Q

TEN v. SJS

A

It is called SJS when less than 10% of the skin is involved

Diagnosis is based on a skin biopsy

Hospitalization

Skin regrows over 2 to 3 weeks. Recovery can take months

128
Q

Chronic Inflammatory Dermatoses

A

Psoriasis - This is autoimmune. Again you can have different severities, different locations, different manifestations. Some ppl have very little or have extension on almost every part of skin.

Seborrheic Dermatitis - more common than psoriasis- regions with high density of sebaceous glands- scalp and forehead, nasolabial folds Flaky scales Unknown etiology

Lichen planus
Pruritic, purple, polygonal, planar, papules and plaques
Disorder of skin and mucosa
White dots or lines, Whickham striae

129
Q

Blistering (Bullous) Diseases

A

Pemphigus

Bullous Pemphigoid

Dermatitis Herpetiformis

130
Q

Pemphigus

A

Inflammatory- Pemphigus- Autoantibodies
Primary lesions are superficial vesicles and bullae that rupture easily
Oral ulcers may persist for months

131
Q

Bullous Pemphigoid

A

Chronic inflammatory subepidermal blistering disease

132
Q

Dermatitis Herpetiformis

A

Inflammatory disorder
Blisters- Itchy papulovesicular eruptions
May be associated with Celiac disease

Bilateral and symmetric

133
Q

Noninflammatory Blistering Disorders

A

Epidermolysis Bullosa
- blisters at sites of pressure, rubbing or trauma
Inherited disorder- minor to fatal

Porphyria

134
Q

Porphyria

A

Metabolic disorders- excretion of porphyrins- purple red pigments
Genetic factors and environmental factors
Sensitivity to light
Lesion in the skin- blistering
Affects the nervous system
Attacks may be triggered by smoking stress and certain medications

Complications
High blood pressure
Chronic kidney failure
Live damage

135
Q

Disorders of Epidermal Appendages

A

Acne vulgaris

Rosacea

136
Q

Acne vulgaris

A

Hair follicles clogged
Primarily- areas with high number of oil glands Genetics
Role of diet and smoking is unclear
Hormones

137
Q

Rosacea

A

Common skin disease Etiology unknown-
Triggers- heat, stress, sunlight, alcohol, caffeine, spicy foods
People over 30

Flare-ups
Redness on nose, cheeks, chin and forehead Dilated blood vessels
Papules, pustules and swelling May be burning and sorenes

138
Q

Panniculitis

A

Group of diseases
Inflammation of the subcutaneous adipose tissue
Skin tender nodules

Erythema Induratum ( nodular vasculitis) TB, hepatitis C

Erythema nodosum- Associated with infections, IBD, oral contraceptives, pregnancy sarcoidosis

139
Q

Skin Infection

A

Verrucae (Warts)

Molluscum Contagiosum

Impetigo

Superficial Fungal Infections

140
Q

Why is in important for dentists to understand Hemostasis and Coagulation Disorders?

A

Gingival bleeding often the first sign of a bleeding disorder

Dental extractions often herald bleeding diatheses

141
Q

HEMOSTASIS

A

Maintenance of clot-free, flowing blood within the vascular system, while also allowing the rapid formation of a solid clot to close ruptures/injury

142
Q

FIBRINOLYSIS

A

The dissolution/breaking apart of fibrin clots; a normal component of hemostasis

143
Q

THROMBOSIS

A

the formation of a clot within the uninterrupted vascular system; a pathologic extension of hemostasis

144
Q

DIATHESIS

A

A condition which makes the body tissues react with heightened susceptibility; clot too easy
(e.g., bleeding diathesis)

145
Q

COAGULOPATHY

A

Any disorder of blood coagulation (bleeding or thrombosis)

146
Q

Development of a Hemostatic Plug

A

Blood Vessel Injury (usu. endothelial)

Immediate Vasoconstriction (neurogenic) Platelet

Adhesion to Collagen

Platelet Activation

Coagulation Cascade-Permanent Fibrin/Platelet Clot

(Induction of Fibrinolysis)

147
Q

The Vascular Endothelium and the Balance of Clot Formation

A

The vascular endothelium, when uninjured, it has an anticoagulant function, or blood flow function and when injured, it has a pro-coagulant function.

148
Q

Two components of the platelets that are very important in normal blood clotting

A

Dense Bodies and Alpha Granules

149
Q

Platelet Activation

A

Adhesion & Shape Change: platelets adhere to
nonendothelial injury site
(e.g., collagen). Big players: vWF, GPIb
Platelets bind to vWF via GP1b on its surface basically forming the bridge that allow the platelet to adhere to the collagen.

Secretion: Alpha granules and dense bodies released.

Aggregation: platelets attach to each other via GPIIb/IIIa and fibrinogen which is one of the many coagulation proteins that normally circulates in your vascular system and is made in the liver. So fibrinogen is the bridge b/w platelets in the step of aggregation.

150
Q

Where is vWF made?

A

In the endothelial cells

*only one of the coagulation proteins not made in the liver

151
Q

Role of Calcium in normal homeostasis

A

Ca++ critical in all stages of platelet activation; the more Ca++ in platelets, the more activation there is

152
Q

Relationship of vessel injury and activation

A

The more vessel injury there is, the more platelet activation there is

153
Q

Extrinsic arm of Coagulation Cascade

A

Starts with Tissue Damage

When there’s tissue damage, there’s something called tissue factor released from the endothelium, and it initiates the coagulation cascade.

the coagulation cascade starts with INACTIVE Factor 7 which (with the tissue factor and the platelet activation) turns factor 7 to factor 7A. “A” means that its ACTIVATED

activated factor seven then jumps right into this final pathway of the coagulation cascade. This final pathway is called the common pathway.

The final common pathway always ends with factor 10 getting activated.

Then factor 5 gets activated through factor 2 (Prothrombin –> Thrombin (IIa))

And Thrombin (IIa) transforms Fibrinogen is into fibrin.

154
Q

Intrinsic Pathway

A

Begins with more subtle microscopic injuries are called intrinsic injuries.

As a result of that, factor 12 is activated to factor 12A, factor 11 then factor nine, then finally factor 8.

155
Q

Which factors are Vitamin K-dependent?

A

Factors II, VII, IX, and X

156
Q

Gall bladder and bleeding disorders

A

if the gall bladder is not functioning properly, you can’t absorb a fat-soluble vitamin like vitamin K, you might have a bleeding disorder because 4 factors are going to be effected by deficiency of vitamin K

157
Q

if you’re suspicious of a bleeding disorder, how do you confirm or rule out your suspicions?

A

run a coagulation profile

158
Q

How Are Abnormalities of Hemostasis Diagnosed?

A

Incidental lab result in a pre-op or medical work-up

Patient presents with bleeding complaints

Patient gives a personal or family history of bleeding

159
Q

The Coagulation Profile

A
Platelet count (CBC)
Bleeding Time (BT)
PT
PTT
Specific Factor Assays
160
Q

Normal amount of platelets are

A

150,000-400,000

161
Q

Abnormal Bleeding Time (BT)

A

Qualitative Platelet Defects and Vessel Wall/CT Disorders like Marfan’s syndrome

162
Q

Decreased platelet count and Prolonged BT

A

Thrombocytopenia

163
Q

Prolonged PT

A

Deficiencies of Extrinsic Pathway (i.e., VII)

164
Q

Prolonged PTT

A

Deficiencies of Intrinsic Pathway

165
Q

Prolonged PT and

PTT

A

Deficiencies of Common Pathway

166
Q

Two Classifications of Coagulation Disorders

A

1) Bleeding Diathesis (aka abnormal bleeding)

2) Thrombotic Diathesis

167
Q

Vascular Disorders

A

Relatively common
Mostly acquired and often treatable
Mostly small hemorrhages (petechiae, purpura)
Coag. Profile: Normal or +/- prolonged BT

structural abnormality of the blood vessels and connective tissue disroders like Marfans, or something like that.

168
Q

Vascular Disorders: Acquired Causes

A

Infectious (esp. meningococcemia, rickettsiae, bacterial endotoxins)

Drug-Induced Vasculitides

Collagen-Vascular Diseases (e.g., SLE)

Age (poor connective tissue, malnutrition)

Vitamin C Deficiency (scurvy)-rare

Cushing’s Syndrome (wasting)

169
Q

Vascular Disorders: Hereditary Causes

A

Ehlers-Danlos Syndrome (connective tissue disorder)

Henoch-Scholein Purpura (vasculitis)

Hereditary Hemorrhagic Telangiectasia

170
Q

Platelet Disorders General Categories

A

– Thrombocytopenias (reduced platelet count)

– Thrombocytopathies (defective platelet function)

171
Q

Thrombocytopenias

A

Vast majority acquired/iatrogenic

Signs/symptoms: (small vessel) bleeding from skin, mucous membranes of gingiva, GI, and GU tracts (hematuria)–petechiae, purpura

Bleeding from surgery or trauma when counts
20-50,000

Spontaneous bleeding only if <20,000

Increased risk of intracranial bleeds if <10,000

Coag. Profile: low plt count, prolonged BT

172
Q

Thrombocytopenias: Causes

A

Infiltrative bone marrow diseases
(leukemias, metastatic cancers)

Defective platelet production (aplastic anemia, suppressive drugs/ chemotherapeutic agents, alcoholism, B12/ folate deficiency, HIV/AIDS)

Increased platelet destruction in blood (infectious agents, certain drugs, splenomegaly, anti-platelet Ab’s in ITP & AIDS, TTP, prosthetic heart valves, HTN, DIC, atherosclerosis)

“Dilutional thrombocytopenia” (from massive transfusions)

(Rare hereditary diseases)

173
Q

Thrombocytopathies

A

Defective platelets
Vast majority acquired/iatrogenic
Similar presentations to patients with thrombocytopenias

Coag. Profile: Normal platelet count, prolonged BT

174
Q

Thrombocytopathies: Acquired Causes

A

**Aspirin (ASA): 1000mg prolongs BT significantly and irreversibly for 10 days!

NSAID’s (ibuprofen, indomethacin, etc.): effects last only 1-2 days, except ibuprofen, which lasts 10 days as ASA does

Uremia (end stage renal disease)

Liver Disease

Alcoholism

175
Q

Thrombocytopathies: Hereditary Causes

A

Bernard-Soulier Syndrome: Aut. rec.,
GPIb deficiency–adhesion dysfunction

Glanzmann’s Thrombasthenia: Aut. rec., GPIIb/ IIIa deficiency–aggregation dysfunction

Storage Pool Disorders: Usually aut. rec., alpha and dense granule deficiencies–secretion dysfunction

176
Q

The Hemophilias (Factor Deficiencies)

A

Vast majority acquired

Presentation: Deep bleeding
(e.g., hemarthroses, GI/GU bleeding), ecchymoses (bruises)/hematomas following trauma, prolonged bleeding following a cut or surgery.

Petechiae/purpura UNCOMMON

Coag. Profile: (usu.) Normal plt count; prolonged PT &/or PTT

177
Q

Acquired Hemophilias: Major Causes

A

Vitamin K Deficiency &/or Intestinal Malabsorption
Liver Disease
Renal Insufficiency/Failure
DIC
Acquired vWD
Acquired Anti-Factor Antibodies (Inhibitors)

178
Q

Vitamin K Deficiency

A

Deficient factors II, VII, IX, and X

Prolonged PT (and PTT)

Common in malnourishment, alcoholism, gallbladder disease/biliary obstruction, intestinal disease (with malabsorption), neonatal period (esp. preemies and breast-fed neonates)

Treatment: Oral/IM/IV Vitamin K

PT/PTT correct (if liver healthy) within days with oral tx, 24hrs with IM tx, and 3hrs with IV tx

179
Q

Liver Disease

A

All coag. factors (except vWF) synthesized in liver; therefore, all potentially affected in severe liver disease (e.g., cirrhosis)

85% of liver disease patients have at least one
hemostatic abnormality

15% have clinical bleeding

Vit K-dependent factors affected first

Coag. Profile: prolonged PT early in disease course; prolonged PTT only with severe disease; (+/- decreased platelet count &/or prolonged BT)

Treatment:
– Fresh Frozen Plasma (FFP)-has all factors except XII
– Treat underlying liver disease, transplant

180
Q

Causes of Coagulopathies in Liver Disease

A

Decreased factor production in damaged liver cells (bleeding)

Production of abnormal (nonfunctional) factors
(bleeding)

Decreased platelet # or function (bleeding)

Impaired clearance of activated factors
(thrombosis)

181
Q

Disseminated Intravascular Coagulation (DIC)

A

Complex, secondary complication to a variety of conditions

Patients usually hospitalized &/or severely debilitated (sepsis, malignancies, shock, severe burns, transfusion reactions, liver disease, **obstetrical complications)

Begins as excessive, multifocal thromboses; after a period, platelets and factors consumed, causing life- threatening hemorrhage &/or thromboses (strokes, MI’s, ARF)

Coag. Profile: Prolonged PT and PTT, decreased platelets and fibrinogen, increased fibrin split products

Treatment: Very difficult; double edged sword; treating underlying condition is best approach, but often impossible

182
Q

Hereditary Hemophilias

A

Von Willebrand’s Disease (VWD)

Hemophilia A

Hemophilia B (Christmas Disease)

(All other factor deficiencies-exceedingly rare)

183
Q

VWD

A

Very common (frequency 1%), but highly variable & often subclinical until a procedure is performed (often dental!)

Most cases autosomal dominant; variable family histories; men and women equally affected

3 types: I-III (mild-severe), III being rare and aut. recessive

Defective platelet adhesion and decreased Factor VIII level/activity

Variable Presentations: Asymptomatic to spontaneous bleeding from mucous membranes, menorrhagia, etc. Usually similar to platelet coagulopathy presentations

184
Q

VWD Coagulation Profile

A

(variable) +/- prolonged BT; normal plt count; +/- prolonged PTT
* *Abnormal Ristocetin Test, decreased Factor VIII levels

Diagnosis: often difficult due to variability of disease; must have a high index of suspicion

Treatment: Cryoprecipitate (VWF + VIII) before surgical/dental procedures

185
Q

Hemophilia A

A

the most common hereditary coagulation disorder causing serious (deep) bleeding

Factor VIII deficiency &/or dysfunction

X-linked recessive: Mothers are carriers, passing disease on to their sons (only rare female carriers with symptomatic disease)

Presentation: Deep bleeding, hemarthroses with crippling deformities; petechiae and ecchymoses characteristically absent

30% with no family history (brothers, maternal uncles, etc.); new mutations?

Coag Profile: Normal platelet count; Prolonged PTT; decreased Factor VIII assay
or activity

Treatment: Frequent cryoprecipitate or
**Factor VIII concentrate (recombinant lowest risk of disease transmission)

Complications: Crippling joint deformities, AIDS, hepatitis, hemochromatosis, life-threatening hemorrhages

186
Q

Factor VIII Activity in Hemophilia A and severity

A

6-50% Factor VIII activity = mild disease
2-5% Factor VIII activity = moderate ds
< 2% Factor VIII activity = severe ds

187
Q

Hemophilia B (Christmas Disease)

A

X-linked recessive (mother to sons)

Factor IX deficiency or dysfunction

Clinically indistinguishable from Hemophilia A

Presentation: Depends on Factor IX level/ activity; from asymptomatic to deep bleeding/hemarthroses

Coag. Profile: Normal plt count; prolonged PTT & reduced Factor IX assay/activity

Treatment: Factor IX concentrate

188
Q

Thrombotic Disorders: Causes

A

Hematologic Abnormalities: Excessive platelet production (e.g., essential thrombocytosis), RBC production (p. vera, COPD), or WBC production (leukemias)

Malignancies (hypercoagulability, DIC)

Multiple Myeloma (increased protein in circulation)

Oral Contraceptives, Pregnancy

Smoking, Atherosclerosis

Prosthetic Heart Valves

Post-operative Periods (immobilization and increased platelets)

(Rare) Hereditary Deficiencies of Natural Coagulation Inhibitors

189
Q

Anemia

A

Definition:
Reduction in red cell measurement on CBC:
Hb less normal range or decreased Hct (ratio of packed RBCs to total blood volume)
Low RBC count
Reduces oxygen carrying capacity
Leads to hypoxia/ischemia

190
Q

Bleeding and Anemia

A

You can have anemia if you have a profuse bleeding. But anemia doesn’t cause bleeding

191
Q

HEMATOCRIT(HCT) or PCV ( packed cell volume) or erythrocyte volume fraction (EVF)

A

the volume percentage of red blood cells in the blood. It can indicate if there is a problem, but cannot determine the underlying condition

192
Q

Who has more RBCs? Males or Females?

A

Males they have more, females have less.

193
Q

Mechanistic Classification of Anemia

A

Blood Loss
Decreased Production
Hemolytic (increased destruction)

194
Q

Common Clinical Features of Anemia

A
Weakness
Fatigue
Dyspnea on mild exertion
Light-headedness, headache
Pallor and/or jaundice
Rapid pulse
Skin atrophy; brittle, concave finger nails  (koilonychia)
195
Q

Iron Deficiency Anemia cells look like

A

Microcytic and hypochromic cells

196
Q

Iron and Hepicidin

A

Absorption closely modulated by hepcidin
Hepcidin inhibits iron absorption in enterocyte and iron release by macrophages
In iron deficient states, hepcidin levels are low and iron absorption is increased

Absorbed proximal duodenum
Absorption regulated by hepcidin made in liver and released in response to intrahepatic iron levels
When body has enough iron, hepcidin inhibits absorption into blood by keeping it in mucosal cells (as mucosal ferritin)
When hepcidin low, more iron absorbed

197
Q

PICA is a symptom of

A

Iron deficiency microcytic anemia

198
Q

Iron Deficiency Anemia

A
Oral manifestations:
“Burning” tongue
Patchy or diffuse erythema
Atrophy of filiform papillae
Taste alteration
Fissuring
Angular Cheilitis
199
Q

PLUMMER VINSON SYNDROME

A

Iron deficiency anemia caused by malnutrition, malabsoption

Northern European women 30-50 yrs

Esophageal web-

Anemia, glossitis and dysphagia

risk of squamous cell carcinoma (esophagus, oral, pharyngeal)

200
Q

Decreased RBC production

A

Lack of nutrients: B12 and folate
Bone marrow issues: aplastic anemia, red cell aplasia, acute leukemia, metastatic tumors

Erythropoietin deficiency: renal failure

Chronic disease /inflammation /malignancy: decreased GI absorption of iron, reduced release from macrophages, relative low erythropoietin

201
Q

Increased RBC destruction

A

Inherited:
Sickle cell disease
Thalassemia (specifically the major one because the other ones are not going to have the same manifestations)
Hereditary Spherocytosis (which is a very rare inherited disease).

Acquired: there are different things that can cause increased destruction:
Malaria
Parvo 19 infection
HUS (hemolytic uremic syndrome - something related to kidney function)
TTP thrombotic thrombocytopenic purpura
DIC disseminated intravascular coagulation (this can happen with different conditions. This will not only cause problems with RBCs but the major issue is with the platelets. The crazy coagulation that can happen and it can effect the number of RBCs.)
Drug Induced (you will see in Pharmacology different medications that can have this effect too.) And
Autoimmune hemolytic anemia. Like that is related to how the immune system works.

202
Q

RBC Hemolysis

A

Shortened erythrocyte life span < 100 days (normal lifespan is 120)
Accumulate products of hemoglobin catabolism (iron)
Marked increase in erythropoiesis
Problems within erythrocyte (intracorpuscular /intrinsic)
Problems outside erythrocyte (extra corpuscular /extrinsic)

203
Q

Hemolytic anemia cellular appearance

A

This occurs in hemolytic anemia.
You see irregularities
Target cell – has something in the center

People can call it in diff ways – some look like helmets = they call is schistocytes, fragmented red cells
They call it in completely different names
In reality, cells in different shape.

204
Q

Major consequences of anemia

A

Clinical presentation depends on
severity
speed of onset
underlying pathogenic mechanism

Compensatory mechanisms
increase in plasma volume
increase in cardiac output
increase in respiratory rate

Hyperbilirubinemia, jaundice, and pigmented gallstones

Inappropriately high levels of iron absorption from gut (iron overload)

Childhood-Growth retardation, skeletal abnormalities

205
Q

Severe long-standing anemia

A

Fatty change
Reversible accumulation of fatty vacuoles in cytoplasm in response to hypoxia (and to some other insults)
Main organs affected
Liver, myocardium, kidneys

206
Q

Pernicious anemia

A

problems with vitamin B12 deficiency
Macrocytic megaloblastic anemia
Bigger cells – takes more volume in blood

Lack intrinsic factor
Autoimmune destruction of parietal cells in fundus Atrophic gastritis
Defective DNA synthesis

Common signs of anemia and neuro changes Symmetric paresthesia, Jaundice from hemolysis of RBCs, removal of abnormal RBC
Demyelination of dorsal + lateral tracts in spinal cord
Gives rise to sensory ataxia. Neuropsychiatric symptoms such as psychosis and dementia

207
Q

Macrocytic Anemia (2 types)

A

Megalobastic = B12 and folate deficiency

Non-megalobastic = alcohol reticulocytosis, liver disease, hypothyroidism

208
Q

Cobalamin /vitamin B12 deficiency

A

Necessary for DNA synthesis
In acidic stomach, B12 binds to intrinsic factor(IF) stomach
Vit B12 + IF / small bowel ,intestinal absorption in terminal ileum- transcobalamin
Deficiency: decreased absorption or
decreased intake for vegans

209
Q

B12 deficiency Malabsorption causes

A

Malabsorption may be limited:
Lack intrinsic factor so cannot absorb B12 from gut (pernicious anemia)
Gastric bypass
Malabsorption process in IBD affecting terminal ileum (Crohn) or resulting from pancreatic insufficiency (pancreatic proteases usually help release bound B12) or from bacterial overgrowth (utilizes B12)

210
Q

Only anemia associated with symmetrical paresthesia?

A

Pernicious Anemia

211
Q

Pernicious anemia Oral Manifestations

A
Burning sensation of  tongue, lips, taste  disturbances
Patchy or diffuse  erythema, or pallor
Surface atrophy,  lobulation
Jaundice
Skin may be yellow-gray
212
Q

Folate deficiency

A

Important in DNA synthesis
Megaloblastic anemia
Correct macrocytosis with folate supplementation
No neurological changes**

213
Q

Thalassemia

A

Inherited
Microcytic anemia
Abnormal production and increased RBC destruction

214
Q

Classification of Thalassemias

A

Alpha-thalassemias
Hydrops fetalis (fatal before birth) - -/- -
Hemoglobin H disease (moderately severe anemia): - -/-alpha
Alpha thalassemia trait (similar to beta- thalassemia trait) - -/aa or -a/-a
Silent carrier -a/aa

215
Q

Alpha thalassemia

A

More in people with certain characteristics, living in certain parts of the world – Africa, Mediterranean, middle east and Asia – can be carriers for that or have more common disease
Single mutation – carrier state
This is the most common but asymptomatic
Its only decreased on the alpha chain
Remember, you have two alpha and two beta.

216
Q

Beta thalassemia

A

Its also a characteristic Mediterranean/middle eastern but not common in Africa

Abnormalities are going to have different manifestation: Abnormal Hb: decreased function, altered erythrocyte plasticity, Increased erythrocyte destruction (hemolysis), Extramedullary hematopoiesis

In the body, will have different manifestation

Cooley’s anemia = is the one that has major severities related with that; near absent beta chain synthesis in homozygotes or compound heterozygotes

217
Q

Thalassemia presentation bone**

A

Frontal bossing,
“hair-on-end”

Crew cut appearance of calvaria

Enlarged jaws
‘Honeycomb’ bone pattern

The marrow is more active, it’s going to expand & its going to reduce the cortex.

218
Q

Cell presentation of Thalassemia major

A

Microcytic and hypochromic

. Some of them have like a ‘tear drop’ shape but one of, they say, the characteristic is to have these “target cells”

219
Q

Sickle cell crisis

A

Precipitated by hypoxia, infection, hypothermia, dehydration other
3-10 days
Manifestations
Capillary blockage: – ischemia, infarction. and severe pain

Hemolysis: anemia, jaundice
+/- fever

220
Q

Consequences of crisis

A

Major effects on bones, lungs, liver, brain, spleen (due to vascular occlusion)
Bone pain common in children
Stroke
Sequestration crisis – rapid accumulation of RBC in spleen
Acute chest syndrome
Fever, cough, chest pain, infiltrates and inflammation

Kids feel like they’re having a heart attack

221
Q

Hemolytic

Sickle Cell Anemia Head and Neck Manifestations

A
Reduced trabeculation
“Hair-on-end”
appearance of calvaria
Delayed dental  eruption
Dental hypoplasia  Ischemic
Neuropathy
222
Q

Autoimmune hemolytic anemia AHA

A

Result from drugs
lymphoproliferative disorders collagen vascular diseases malignancy
idiopathic

223
Q

Microangiopathic hemolytic anemia

A

RBCs fragment
Occurs with HUS and TTP
Eclampsia and pre-eclampsia with elevated liver enzymes and low platelets in HELLP
HELLP: hemolysis, elevated LFTs and low platelets
Seen with DIC, snake envenomation
Exposure to ticlodipine and cyclosporine
Mechanical heart valves

224
Q

G6PD deficiency

A

Carried on X chromosome
Chronic or intermittent
Function normally except under oxidative stress with certain meds or acute infection
Present with anemia and jaundice
Meds: quinine, sulfonamides, dapsone, primaquine, fava beans
Bite cells on smear
Confirm diagnosis by checking G6PD levels 2-3 months auer hemolytic event
Normal reticulocytes have this immediately following hemolysis

225
Q

G6PD deficiency cellular appearance

A

Looks like someone took a bite out of the RBC (“bite cells”)

226
Q

Aplastic Anemia

A

Decreased Production: (Pluripotent) Stem Cell Defect

DECREASE ALL BLOOD CELLS

  • precursor cell failure
    Reticulocytes / hypo cellular marrow
    Features: anemia, bleeding disorders, susceptibility to infections
    <500 granulocytes/L (Normal = 3-8,000)
    <20,000 platelets/L (Normal = 150-450,000)
    <10,000 reticulocytes/L (Normal = 50,000)

Microscopically, they’re not going to have cells,but you are going to see large spaces with fatty tissue.

227
Q

Possible Etiology of Aplastic Anemia

A

Idiopathic
Radiation
Drugs: chloramphenicol, sulfonamides, alcohol, chemotherapy
Infections: CMV/EBV, Parvovirus, hepatitis, HIV
Bone marrow transplant in young, immunosuppress in older

228
Q

Aplastic Anemia Oral Manifestations

A

pallor
gingival bleeding, mucosal petechiae, purpura, ecchymoses
gingival enlargement
mucosal ulcers

229
Q

only anemia that the presentation is going to be with gingival bleeding

A

APLASTIC ANEMIA

230
Q

Anemia of chronic disease AOCD

A

Normochromic, normocytic anemia
Defective mobilization of iron to erythrocytes
Low erythropoietin – common in renal disease
Low serum iron, transferrin saturation
Bone marrow not depleted
Treat: iron and erythropoietin

231
Q

Polycythemia

A

Erythrocytosis (INCREASE IN RBCS)

Primary: Clonal, autonomous proliferation of myeloid stem cells (polycythemia vera); often thrombocystosis, leukocytosis

Secondary: increased erythropoietin levels
Compensatory response to host/environment changes: lung disease, high-altitude living, cyanotic heart disease
Response to erythropoietin-secreting tumors (RCC renal cell carcinoma, hepatoma)
Use of erythropoietin

232
Q

Myelodyplastic syndrome MDS

A

Elderly with anemia +/or thrombocytopenia +/ or leukopenia w hyposegmented PMN
Macrocytic anemia with normal B12 and folate
Bone marrow: increased blasts, dysplastic precursors
Primary or secondary due to chemo
Common cause of death is due to low WBCs: infection

233
Q

Normal WBC count

A

varies from 4400 to 11,000 cells/microL (4.4 to 11.0 x 109/L)

(60% are mature neutrophils)

234
Q

Neutropenia

A

absolute neutrophil count (ANC) <1500

implication of neutropenia varies between, mild say if you have WBC between 1000 and 1500 or very severe actually people that have neutrophil count less than 200, they can just die because of an infection.

235
Q

Non Malignant Causes affecting WBC and SCs

A

Infections: HIV, CMV, EBV etc

Medications: Harm WBC or cause BM suppression

Alcohol, B12 or folate deficiencies

Aplastic Anemia (Hypocellular marrow)

Lymphadenitis: Inflammation in LNs and can be associated with lympadenopathy

236
Q

most common reason actually for Neutropenia

A

psychiatric medication. They all cause bone marrow suppression

237
Q

Myeloid and Myeloproliferative Disorders

A
Acute Myeloid Leukemia (AML)
Myeloproliferative Neoplasms (MPN)
    -Chronic Myeloid Leukemia (CML)
   -Polcythemia Vera (PCV)
   -Essential Thrmobocytosis (ET)
   -Primary Myelofibrois (PMF)
238
Q

Acute Myeloid Leukemia (AML)

A

the most common acute leukemia in adults and accounts for approximately 80% of cases in this group

Because the more we live, the more we acquired in our life, some genetic abnormalities. And that’s what leads for the body to misbehave and you can get AML.

So the median age of diagnosis is 65. However, unfortunately recently we’re seeing younger and younger patients.

The incident increases with age, as I mentioned.

Even with the best treatment availability, there’s still a higher risk of relapse, and mortality.

And the five-year survival is not great at all only 24%, and because most of the patients relapse

there’s a mis-behave in the genetic in our body that pathways almost turned on. So basically, yourself are always trying to produce more and more WBC, because you cannot cope, the bone marrow cannot cope to produce all cells including

239
Q

Etiology and Risk Factors

A
Chemical exposure
Benzene, Pesticides
Other environmental exposures
Hair dyes, smoking, non-ionic radiation
Genetic disorders
Down syndrome, Bloom Syndrome, Fanconi’s anemia,  Ataxia-Telangectasia, Wiskott-Aldrich
Prior chemotherapy or XRT
Alkylating agents, Topoisomerase II inhibitors
240
Q

Antineoplastic Agents

A
Alkylating agents
-Preceding MDS phase
-Evolution to AML 5-7 yrs
-Abnormalities: -5 or -7
Topoisomerase II inhibitors
-No MDS phase
-Monocytic morphology
-11q23
241
Q

How we diagnose AML?

A

We do bone marrow biopsy and find they have 20% leukemic cells. Defined as myoblast.

that they are precursors are early cells, like stem cells, they all expressing CD34 positive and HLA-DR. So when they express these two markers, they are very early cells, like stem cells and leukemic cells.

242
Q

Acute Promyelocyte Leukemia (APL)

A
subset of AML
cure rate is 98%
10-15% of AML (FAB M3)
Higher incidence in Hispanics (20-25%) and  with increase BMI
Median Age at Dx is 40yrs
Coagulopathy and hemorrhage
CD 34 and HLA-DR negative
t(15,17) associated with PML/RAR-α fusion
243
Q

AML/APL difference

A

AML, you are stuck in myeloblast, in APL you are stuck the step afterword, which is promyelocyte,

So what happened is that you just matured cells by giving them a medication, a pill. And then the cells start maturing. And you do very well, 98% cure rate

244
Q

Chronic Myeloid Leukemia (CML)

A

Associated with the fusion of 2 genes: BCR (on chromosome 22) and ABL1 (on chromosome 9) resulting in the BCR-ABL1 fusion gene (PHILADELPHIA CHROMOSOME)

15 to 20% of leukemias in adults

The only risk factor that we know of CMS is radiation, people that get exposed to radiation, working in radiation, or even people that get been exposed to high radiation scans or something like that frequently not just once.

245
Q

Three stages of CML

A

1) a chronic phase, 85% of patients at diagnosis
2) an accelerated phase, in which neutrophil differentiation becomes progressively impaired and leukocyte counts are more difficult to control with treatment
3) blast crisis, a condition resembling acute leukemia

246
Q

Myeloproliferative diseases (MPNs)

A

collectively characterized by clonal proliferation of myeloid cells with variable morphologic maturity and hematopoietic efficiency. They are characterized of splenomegaly and JAK2 mutations

2-Polycthehemia Vera (PCV)
PCV is distinguished clinically from the other MPNs by the presence of an elevated red blood cell mass
However, an increased red blood cell mass alone is insufficient to establish the diagnosis, since this is also observed in conditions associated with chronic hypoxia and with erythropoietin-secreting tumors

3-Essential Thrmobosis (ET)
ET has also been called also primary thrombocytosis. It is characterized by excessive, clonal platelet production with a tendency for thrombosis and hemorrhage.

4-Primary Myelofibrosis (PMF)
PMF is the least frequent among the chronic myeloproliferative diseases
Burned out marrow

247
Q

JAK-STAT signaling

A

JAK mutation will lead to:
1, proliferation, so you have more production of cells to certain pathways ;
2, angiogenesis you have more vessels to supply the organs so they can grow and produce more,
3 you have more immunosuppression. the body can be prone to infection, can actually allow cells to grow more and more.

248
Q

Lymphoid and Natural Killers Disorders

A
Acute Lymphoblastic Leukemia (ALL)
Chronic Lymphocytic Leukemia (CLL)
Non Hodgkin’s Lymphomas (NHL)
Hodgkin’s Lymphomas (HL)
NK/T cell lymphomas
249
Q

ALL

A

more frequently presents in its leukemic form than its lymphomatous form
B-ALL accounts for approximately 2% of the lymphoid neoplasms diagnosed in the US
Previous chemotherapy and exposure to radiation increase the risk of developing ALL
Signs and symptoms include fever, feeling tired, and easy bruising or bleeding

Txt: complex 3 year chemotherapy treatment

250
Q

Incidence of different cancers

A

The most common one, on the rise. We’ll talk about it in a bit is CLL. This is hundreds per thousand patient.
The next is, AML, and then come CML and ALL.

If you notice that CLL is significantly under rise. AML actually on the rise and the CML as well, but look at ALL. If anything, you are higher risk for have a younger age and then it goes down and the plateaus doesn’t really increase the risk

251
Q

Better ALL survival rate in children or elders?

A

The younger you are, the better you do so. If you are someone that have an ALL at 15 and 19, that cure rate is 70% now was newer drugs, probably it is around 80%. But if you are 66 year old and you get to leukemic the survival is 30%, because the drugs the chemotherapy that you really need for cure, the body cannot tolerate them. They are meant for young, and healthy pediatric people. So the older the patient gets, it’s very hard to cure.

252
Q

What are the factors that we care about most in ALL?

A

The most important thing we look at is cytogenetics. Philadelphia chromosome: it’s seen in CML and if it’s seen in ALL, it results in a worse outcome. If someone has Philadelphia chromosome, then you’re going to treat them with chemotherapy and again you’re going to give them the pill that you gave patients with CML. The outcome is worse in this case

Age: the younger the better. We always try to give them a pediatric inspired regimen because they do much better.

If they have Philadelphia chromosome mutation or they are old, you’re always going to try to replace their stem cells and that’s what we call high risk. If they are a candidate for stem cell replacement, this is the only cure in the elderly or as they relapse we may not be able to cure them.

253
Q

CLL

A

A subtype of leukemia arising from immunologically less mature lymphocytes that spread to the blood, bone marrow and lymphatic tissues

The longer people live, the greater the risk of CLL

Staging is different. It’s usually based on if you have WBC, if you have the spleen involved, if you have the liver involved, if you have the bone marrow involved or not.
The most important key in CLL and that’s why it’s on the rise is the microenvironment.

Risk Factors:
Family history Age and Gender
Race/Ethnicity: more common in people of Russian and European descent, and hardly ever develops in people from China, Japan, or Southeast Asian countries. It also occurs commonly in black people.
Agent Orange

Prognosis: Majority indolent disease associated with a prolonged (10 to 20 years) clinical course (about 40-50%)

254
Q

Lymphomas

A

Non Hodgkin’s Lymphoma (NHL)
Hogkin’s Lymphoma (HL)
NK/ T cells Disorders

They start taking over the lymph node. The lymph node (or any of these organs) can no longer fit them as they start growing. This is what happens in lymphoma. It presents with large lymph nodes, large spleen, large thymus gland and you have symptoms because of this. Most of the time the symptom is PAIN.
Or you can end up (because there’s so many lymph nodes), you can end up with B symptoms which is fevers, night sweats, and weight loss.

255
Q

The most common lymphoma

A

DL-BCL (diffuse large B cell lymphoma) – it accounts for 70% of lymphomas. Usually the problem happens in the center of the lymph nodes

If the problem happens outside the lymph nodes, it may happen in plasma cells. Plasma cells are part of lymphocytes and then you end up having a different disease called multiple Myelenoma.

Non-Hodgkin lymphoma usually the problem happens inside the germinal center inside the lymph node. The Hodgkin lymphoma is usually outside the germinal center and that’s because the cells mature a little bit more and that’s why you end up with Hodgkin lymphoma.

256
Q

Types of lymphomas

A

Small cells or large cells

This is most of the time when they are small they are INDOLENT lymphoma – slow growing. When they become large cells, the lymph nodes are larger. The lymphocytes are large as a result. They become more aggressive.
This is an example of Non-Hodgkin lymphomas.
Some people when they take a look at this slide (C)  highly aggressive type of lymphoma called Burkit Lymphoma that‘s associated with EBV virus and HIV.
Multiple types of lymphomas that range from indolent to aggressive form.

257
Q

Hodgkin’s Lymphoma

A

Note there’s only really four types of Hodgkin lymphoma and most of the time you can cure it.
Only accounts for 10% of lymphomas.

About 80% cure rate

Cell presentation: OWL.
Looks like an owl, it’s called Reed Sternberg cells.
Very characteristic presentation.
Two cells that are close to each other, usually they have a large cytoplasm and nucleus. That’s what you see in Hodgkin lymphoma.

258
Q

Multiple Myeloma (MM)

A

This is when you end up having a disease called multiple myeloma (MM)
It’s the second most hematologic malignancy. The most common hematologic malignancy = Non-Hodgkin’s lymphoma.
The most common Hodgkin lymphoma  70% of cases diffused largely B cell lymphoma.
It accounts for about 20% of deaths from hematological malignancies and 2% of deaths from cancers.
In 2012, there was about 90.000 patients living with myeloma and every year we’re estimating about 50,000 US people will end up with MM.
Approximately, the risk of having multiple myeloma is 0.7% in men and women. If you have about 150 people, 1 of them will have MM.
Medium age – it’s a disease of the elderly, age 65. The 5 year survival as of 2018 is only 50%. Unfortunately, we lose 50% of the patients so we’re still not doing that good. Dong better than AML, but
How do people present with MM?
What they present with is the CRAB. This stands for Hypercalcemia, Rena, Anemia, and Bone lesions. They have HIGH calcium (note).

259
Q

Treatment Paradigm in MM

A

Induction
HDT/ASCT
Consolidation
Maintenance

260
Q

key of multiple myeloma

A

key of multiple myeloma is lytic bone lesions

261
Q

Immunotherapy

A

Using your own WBC from your immunity to kill your defected WBCs

262
Q

Infectious Prevention

A

Need to treat underlying etiology and use prophylactic antibodies, anti fungal and anti viral

263
Q

Immunotherapy Started in ALL

A

Monoclonals + cytotoxic agents– inotuzumab
Biallelic monoclonal (CD3 + CD19)– blinatumomab
Modified expanded Tcells– CART cells

264
Q

Pulmonary Infections Host defenses

A

Nasal clearance: sneeze, blow or swallow

Tracheobronchial clearance: 3 to 10 mm
mucociliary action, IgA

Alveolar clearance: 1 to 5 mm
macrophages, IgM, IgG, C3b, T cells

265
Q

Inhalation of infectious agent Pathways

A

Virus –> Infection of type I pnuemocytes –> alveolar injury –> interstitial pneumonia

Pyogenic bacterium –> acute inflammatory response to bacterium –> intra-alveolar pneumonia

266
Q

Bacterial pneumonias (types)

A

Community acquired
Nosocomial
Opportunistic

Most bacteria causing pneumonia are oro- and nasopharyngeal flora

267
Q

Bacterial pneumonias

Etiologies

A

Staphlococci (gram +): what you find on your skin
Strep (gram +): is so commonly associated with pneumonia that theres a pneumococcal streptococci (pneumo meaning air/lungs)
Haemophilus (gram -) : children
Psudomonas (gram -): cystic fibrosis
Klebsiella (gram -): alcoholics
Legionella: transplant patients

268
Q

Pneumococcal Pneumonia

A
Streptococcus pneumoniae (pneumococcus)  Gram + 
facultative anaerobic cocci in pairs  

Found in Nasopharyngeal flora in up to 20%

Capsular polysaccharides–antigenically specific–84 types

Types 1,2,3,4 = pathogenic

Extracellular pathogen
Capsule: antiphagocytic property
Pneumolysin (is a chemical that allows it to break open pneumocytes)
Neuroaminidase

Most common cause of community-acquired pneumonia

Frequently follows a viral URI
Bronchial secretions provide environment

Vaccines for young/old offer up to 90% protection

269
Q

Bacterial pneumonias Clinical Presentation

A

Symptoms: Fever, malaise, productive cough and +/- chest pain

Signs: Tachypnea, decreased breath sounds, dullness to percussion

Radiology: Infiltrate(s)

Treatment: Afebrile within 48 to 72 hours after antibiotics

< 10% of pneumonia admissions die!!

270
Q

4 Stages of Bacterial Pneumonia

A
  1. Congestion: bacteria with edema and vascular engorgement
  2. Red hepatization: red cells, neutrophils and fibrin
  3. White hepatization: fibrin, fibroblasts with few neutrophils
  4. Resolution: return to normal
271
Q

Bacterial pneumonias Complications

A

Abscess (lung tissue can die. It can be necrotic)
Empyema (pus in the pleura)
Organization (consolidation of lung/ it is permanently in that white hepatization with scarring and fibrosis)
Bacteremic dissemination…meningitis, endocarditis Bronchiectasis (end up with a chronic lung infection that scars the lung and dilates the airways )

272
Q

Pulmonary abscess

A

Abscess formation: local necrosis of the lung
Following pneumonia

S. aureus, K. pneumoniae, pneumococcus type 3
fungi

Aspiration of infective material

Mixed organisms including oral anaerobic flora
Bacteroides, Fusobacterium, Peptococcus

Septic emboli
deep leg veins or right heart valves Neoplasia–10 to 15% of cases
post-obstructive pneumo

273
Q

Bronchiectasis

A

Chronic necrotizing infection with dilation of airways

Bronchial obstruction
Tumor, foreign body, mucus impaction (COPD)

Congenital or hereditary conditions
Cystic fibrosis, Kartagener’s syndrome

Necrotizing pneumonia
M. Tuberculosis and Staphlococcus infections

274
Q

pneumonia viruses

A
Lower respiratory tract only
Adenovirus
influenza A and B
Respiratory syncytial virus 
Corona
Parainfluennza
Systemic with pulmonary involvement
Measles  
Herpes 1 and 2  Varicella-zoster
Cytomegalovirus  
Ebola
275
Q

Fungal respiratory infections

A

Candidiasis–normal oral flora
Candida albicans
usually aspiration or hematogenous spread

Histoplasmosis–Ohio and Mississippi rivers
Histoplasma capsulatum
Self-limited, chronic and disseminated forms

Coccidiomycosis–Southwest and Far West
Coccidioides immitis

All inhalers become infected
10% have fever, cough and chest pain + skin lesions
San Joaquin Valley fever complex

Pneumocystis jiroveci (carinii)
A true fungus; ubiquitous
Does not cause disease in immunocompetent folks  Inhaled fungi attach to type I pneumocytes
HIV+ with <200 T cells at risk!
276
Q

Pulmonary Tuberculosis General Features

A

Mycobacteria grow slowly and drug sensitivities can take 6 weeks

Mycobacteria are aerobic non-spore forming nonmotile bacilli with a waxy coat

M. tuberculosis and M. bovis cause tuberculosis
M. avium and M. intracellulare afflict immunocompromised folks
M. leprae causes leprosy

M. tuberculosis infects 33% of the world’s population

M. tuberculosis kills 3 million patients yearly
Single most important infectious cause of death

277
Q

Pulmonary Tuberculosis Pathogenesis

A

Pathogenicity: ability to escape initial macrophage and T cell attacks
Cord factor: grow in cords

Lipoarabinomannan (LAM): g- endotoxin-like substance Inhibits macrophage activation by INF-gamma Induces macrophage TNF-alpha secretion
fever, weight loss, tissue damage Induces macrophage IL-10 secretion
suppresses T-cell proliferation

CR3 uptake receptor
faciliates macrophage uptake without respiratory burst

Heat-shock protein
All leading to granulomatous inflammation and destruction by self! (granuloma formation)

278
Q

Pulmonary tuberculosis Possible Outcomes

A

Healed lesions: scars without organisms

Latent lesions: dormant organisms

Progressive primary Tb: massive lung spread

Miliary Tb: massive hematogenous spread

279
Q

Ghon complex

A

lesion seen in the lung in primary tuberculosis. The lesions consist of a calcified focus of infection and an associated lymph node.

280
Q

primary tuberculosis

A

parenchymal subpleural lesion around upper/lower lobe fissure
enlarged caseous lymph nodes draining lung lesion

281
Q

Latent lesions of TB

A

dormant organisms disseminate host weakens…cancer, infection reactivation of infection
Reactivation in 5 to 10% of cases
Lung apices where there is high O2 tension

Possible outcomes
scar with or without therapy
localized cavitation…bronchial…laryngeal…intestinal spread bronchopneumonia “galloping consumption”
lymphangitic spread to other areas of lung or other organs
vascular spread

282
Q

the 2nd leading cause of death in the United States

A

Lung cancer

behind heart disease (#1) and 3rd is lower respiratory disease (also smoking related).

283
Q

Leading cancer causing death

A

Lung cancer

284
Q

Lung Cancer Causes

A

tobacco – 90% of lung cancers
Environment
Infections – NO!!!!!!!!!!!!!!
Diet – (if you eat well it probably indicates a confounding variable that you’re of a higher SES so you’re less likely to smoke)
Genes - play a HUGE role but it’s often hard to tease out as we’ll see because smokers usually grow up in households where the parents smoked

285
Q

Lung cancer & Tobacco smoke

A

Tobacco smoke causes 90% of lung cancer
1.9% of men, 13.0% of women non-smokers!!

Duration and intensity of smoking correlate with incidence and mortality

Low tar-low nicotine cigarettes–cotinine levels!!

Involuntary or passive smoking is a proven cause of lung cancer

286
Q

smoking causes these cancers

A
Oropharynx
Larynx
Esophagus 
Trachea
Bronchus
Lung
Leukemia 
Stomach
pancreas
Kidney
Ureter
Cervix 
Bladder
287
Q

What happens when you quit smoking?

A

20 minutes later your BP will drop, your CO levels will return to normal, things will taste better, your lung function will improve, your risk of heart disease will drop in a very short time, your risk of stroke will drop in a short time. Your risk of dying from lung cancer over about 20 years it will take to come back to the risk of almost a non smoker – it never comes down but close

288
Q

What’s the risk of smoking and asbestos?

A

Synergistic-multiplicative effect with tobacco smoke

289
Q

Non-tobacco procarcinogens

A

Asbestos
Indestructible and fire resistant fibers Amosite, tremolite, chrysotile, crocidolite Incite inflammation, fibrosis, malignancies

Nickel compounds
Copper compounds  
Arsenic compounds  
Chromate compounds  
Mustard gas
Benzene
290
Q

Radiation and Lung Cancer

A

Radioactivity in cigarette smoke
Alpha emitters polonium-210 and lead-210
Particles accumulate at bifurcations of segmental bronchi
1.5 packs per day = 300 CXR per year to the skin

Radon…gaseous product of radium-226 decay
Half life 3.8 days; decays into 2 alpha emitting daughters Particles deposit on dust inhaled into the bronchial tree Beware of well insulated airtight homes in the Reading Prong Synergism between decay products and tobacco smoke 2nd cause of lung cancer in US according to EPA
20,000 deaths per year

Uranium
Navajo uranium miners

291
Q

Lung cancer

Genetic/Molecular observations

A

EGFR mutations most commonly found in women (non-smokers with lung cancer)

292
Q

Lung cancer Clinical features

A

Peak age 60-70 years, range 11-whenever

Slight male predominance
Symptoms:
    asymptomatic
     cough or change in existing cough  
     weight loss
     chest pain  
     dyspnea
     wheezing/stridor/hoarseness  
    sputum production/hemoptysis  
     SVC syndrome
    Pancoast syndrome
   Paraneoplastic syndromes  
   metastatic disease
293
Q

Paraneoplastic syndromes

A

Symptom complexes not explained by tumor or hormones produced by organ involved by tumor.

Occurs in 1-10% of lung cancer patients

Hypercalcemia  
Hypocalcemia  
Gynecomastia  
Carcinoid syndrome  
Cushing syndrome
Eaton-Lambert myasthenic syndrome
Syndrome of Inappropriate ADH secretion (SIADH)
294
Q

Lung cancer

Diagnostic procedures

A

Cytology
sputum
bronchial wash/brush
fine needle aspiration

Transbronchial biopsy

Mediastinoscopy or scalene lymph node biopsy

Surgical resection
wedge biopsy
lobectomy
pneumonectomy

295
Q

Lung Cancer Classification

A

Small cell carcinoma (SCLC) 25%

Non-small cell carcinoma (NSCLC) [including rare salivary gland-types]
75%

296
Q

Small cell carcinoma

A
HORROR OF HORRORS
Smoking-related
Widespread at the time of diagnosis 
Paraneoplastic syndromes
Initially responsive to chemotherapy 
Anatomic extent of limited disease can be included  within an irradiation field (limited to area 30%)
There are almost NO survivors

Present with systemic complaints…H/A, fatigue…
Up to 85% have extrathoracic disease at diagnosis Present with paraneoplastic syndromes
SIADH or Cushing syndrome
5 year survival = 4%
Gross features
often virtually undetectable bronchial wall lesions Microscopic features
small cells with little cytoplasm dark nuclei without nucleoli mitotically active

297
Q

Lung Squamous cell carcinoma

A

Non-small cell carcinoma been the most common type for years

Most common type found in men

Correlates with smoking
Usually central/hilar location = 15% 5 year survival

Microscopic features
squamous metaplasia keratinization intercellular bridges leading to dysplasia and then carcinoma

298
Q

Lung Adenocarcinoma

A

Non-small cell carcinoma arising from a glandular cell & NOT from a squamous cell.**
And, it is most common type in women & non-smokers.

Usually peripheral location 5-25% 5 year survival associated with scars

Gross features
can be very very small, but still very very bad!

Microscopic features 
acinar  
papillary  
micropapillary 
 solid
lepidic
299
Q

TNM staging T

A

T1: <= 3 cm
not within the main bronchus

T2: > 3 cm but <= 5 cm
Involves the main bronchus but not carina Invades visceral pleura
Any tumor causing atelectasis or pneumonia to hilum

T3: > 5 cm but <= 7 cm
Any tumor extending into chest wall, diaphragm, pericardium Any tumor in the main bronchus within 2.0 cm of the carina Separate cancer in the same lobe!

T4: > 7 cm
Any tumor invading mediastinum, heart, esophagus… Any tumor involving the carina
Separate cancer in same side lung but different lobe

300
Q

TNM staging N

A

N0: No nodes

N1: Peribronchial or ipsilateral hilar nodes

N2: Ipsilateral mediastinal nodes or subcarinal nodes

N3: Contralateral hilar or mediastinal nodes; any neck nodes

301
Q

TMN staging M

A

M0: No known metastases

M1: Separate carcinoma in other lung
Pleural nodules
Malignant pleural effusion
Distant metastasis

Regional lymph nodes (>50%)*** 
Adrenal gland (>50%)
Liver (30-50%)
Brain (20%)
Bone (20%
302
Q

Most common malignant neoplasms of the lung

A

carcinomas, sarcomas metastasis

NOT LUNG CANCER